Zunaglim MV 1mg/500mg/0.2mg Tablet
Marketer
Zunarsh Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Zunaglim MV 1mg/500mg/0.2mg Tablet
Diabetic patients may use the combined anti-diabetic medication, GlyZun 1mg/500mg/0.2mg tablet, to manage type 2 diabetes. This medication helps regulate blood glucose in adults. GlyZun should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Zunaglim MV 1mg/500mg/0.2mg Tablet
There is no text provided to rephrase.
Uses of Zunaglim MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Zunaglim MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Zunaglim MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Zunaglim MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Zunaglim MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Zunaglim MV 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Zunaglim MV 1mg/500mg/0.2mg Tablet works:
Each Zunaglim MV tablet (1mg/500mg/0.2mg) contains a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zunaglim MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Taking Zunaglim MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Zunaglim MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Employing Zunaglim MV 1mg/500mg/0.2mg tablets in individuals with kidney disease carries a high risk and is best avoided. Medical advice is essential. Furthermore, its use is contraindicated for patients experiencing severe renal impairment.
LiverCAUTION
Patients with liver impairment should use Zunaglim MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Consult a physician. For individuals with mild to moderate liver disease, a low initial dose is typically prescribed; however, use is contraindicated in those with severe liver dysfunction.
What if you forget to take Zunaglim MV 1mg/500mg/0.2mg Tablet :
Should you forget to take your Zunaglim MV 1mg/500mg/0.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zunaglim MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently